Like Quintiles Transnational Corp.

closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 9/25/2017 via BusinessWire

Konica Minolta, Inc., will acquire Invicro, LLC

synopsis: Konica Minolta, Inc. and Boston-based Invicro LLC announced that they have concluded an agreement whereby Konica Minolta will acquire Invicro, a leading provider of imaging services and software for research and drug development.
buyer: Konica Minolta, Inc. (TSE:4902:$9,557.68)
Konica Minolta, Inc. is a Japanese technology company headquartered in Tokyo. The company manufactures business and industrial imaging products, including copiers, laser printers, multi-functional peripherals (MFPs) and digital print systems for the production printing market. "
target: Invicro, LLC
Invicro is a leading provider of imaging services and software for research and drug development. Headquartered in Boston, Massachusetts, Invicro LLC was founded in 2008 with the mission of improving the role and function of imaging in drug discovery and development across all therapeutic areas.
price ($mm)
rev ($mm)
$106
EBITDA ($mm)
$17
EV / rev
0.0x
EV / EBITDA
0.0x
closed 8/16/2017 via BusinessWire

Evotec BioSystems GmbH, acquired Aptuit, Inc.

synopsis: Evotec announced that it has successfully completed the acquisition of Aptuit, a partner research organisation for integrated outsourced drug discovery and development solutions. This acquisition adds considerable business opportunities to further accelerate Evotec's long-term strategy to be the industry partner of choice for external innovation.
buyer: Evotec BioSystems GmbH (XTRA:EVT:$226.46)
Founded in Hamburg Germany, Evotec BioSystems GmbH is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. "
target parent: Welsh, Carson, Anderson & Stowe
target: Aptuit, Inc.
Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators.
price ($mm)
$300
rev ($mm)
$93
EBITDA ($mm)
$12
EV / rev
3.2x
EV / EBITDA
25.8x
announced 6/20/2017 via Company Press Release

Pamplona Capital Management LLP, will acquire PAREXEL International Corporation

synopsis: Pamplona Capital Management, LLP has entered into a definitive agreement to acquire all of the outstanding shares of PAREXEL International Corporation, a leading global biopharmaceutical services provider. PAREXEL provides a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services.
buyer: Pamplona Capital Management LLP
Pamplona Capital Management is a London, New York, and Boston-based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds, and single-manager hedge fund investments. "
target: PAREXEL International Corporation (PRXL:$1,939.36)
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries.
price ($mm)[EV]
$4,508 [$4,923]
rev ($mm)
$2,097
EBITDA ($mm)
$343
EV / rev
2.4x
EV / EBITDA
14.6x
announced 5/10/2017 via BNC Analysis

inVentiv Health, Inc. will be merged with INC Research, Inc.,

synopsis: INC Research Holdings, Inc., a leading global Phase I-IV Contract Research Organization ("CRO"), and inVentiv Health, Inc., a leading, global CRO and Contract Commercial Organization will merge. INC Research shareholders will own approximately 53 percent and inVentiv shareholders will own approximately 47 percent of the merged entity.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. "
target parent: Thomas H. Lee Partners, L.P.
target: inVentiv Health, Inc.
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Their Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services.
price ($mm)[EV]
$2,453 [$4,552]
rev ($mm)
$2,156
EBITDA ($mm)
$306
EV / rev
2.1x
EV / EBITDA
14.9x
closed 11/6/2009 via BusinessWire

PPD, Inc., acquired Excel PharmaStudies Inc.

synopsis: PPD, Inc. announced it has completed its acquisition of Excel PharmaStudies, Inc., one of the largest contract research organizations in China. The acquisition strengthens PPD’s full range of drug development services in the country and positions it to capitalize on the tremendous growth of the outsourcing market in Asia Pacific.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: Excel PharmaStudies Inc.
Excel PharmaStudies, Inc. is a full-service provider of clinical research, registration, biometrics, and training and consultation services. Excel is the leading CRO in China and operates 22 offices worldwide, with more than 300 staff members.
price ($mm)
$16
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2009 via PR Newswire

Pierrel SpA, purchased US Operations from Encorium Group Inc.

synopsis: Encorium Group, Inc., a full service multinational clinical research organization, announced that is has completed the previously announced sale of the Company's U.S. business to Pierrel Research USA, Inc., a wholly-owned subsidiary of Pierrel SpA, an international contract research organization listed on Milano's Stock Exchange.
buyer: Pierrel SpA (PIELF:$0.00)
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use. "
seller: Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
price ($mm)[EV]
$0.08 [$2.58]
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 4/8/2009 via PR Newswire

Next Fuel, Inc., will acquire Clinical Trials of the Americas, Inc.

synopsis: Clinical Trials of America Inc. announced that it has entered into a binding letter of intent to sell shares equal to approximately 75% of its issued and outstanding shares to Next Fuel Inc., a developer of a proprietary "On Demand" Hydrogen Generation System.
buyer: Next Fuel, Inc.
Next Fuel Inc. is a developer of a proprietary "On Demand" Hydrogen Generation System that is used as fuel for Fuel Cells which produce electricity. "
target: Clinical Trials of the Americas, Inc.
Clinical Trials of the Americas, Inc. provides clinical trial investigator services in dedicated sites throughout the Americas. Initially, we intend to introduce our services in Central America.
price ($mm)
$0.29*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/2/2009 via PR Newswire

ASG, Inc., acquired Ockham Development Group, Inc.

synopsis: ASG, Inc. a high-quality functional outsourcing and specialty staffing services group based in Cary, North Carolina - has acquired neighboring Ockham Development Group, Inc., a full-service contract research organization.
buyer: ASG, Inc.
ASG provides high-quality functional outsourcing and specialty staffing services to CROs, pharmaceutical, biotech and medical device companies that require clinical operations, GCP, GLP or GMP auditing, data management, statistical programming, biostatistics and medical writing solutions. "
target: Ockham Development Group, Inc.
Ockham Development Group Inc. is a privately held contract research organization headquartered in Cary, North Carolina.
price ($mm)
rev ($mm)
$12
EBITDA ($mm)
EV / rev
0.0x
EV / EBITDA
closed 4/22/2009 via BusinessWire

PPD, Inc., acquired AbCRO, Inc.

synopsis: PPD, Inc. announced that it has completed the acquisition of AbC.R.O., Inc., a Bulgarian contract research organization. The acquisition strengthens PPD’s ability to provide a broad range of clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs services to its growing client base in the Balkans.
buyer: PPD, Inc.
PPD is a leading global contract research organization (CRO) providing discovery, development and post-approval services as well as compound partnering programs. PPD's clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. "
target: AbCRO, Inc.
AbCRO provides a full range of Phase II-IV clinical services, including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
price ($mm)
$36
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/20/2009 via PR Newswire

PharmaNet Development Group, Inc. merged with JLL Partners,

synopsis: JLL Partners, a leading private equity investment fund, and PharmaNet Development Group, Inc., a leading provider of clinical development services, announced the successful completion of the tender offer by JLL PharmaNet Holdings, LLC.
buyer: JLL Partners
Founded in 1988, JLL Partners is among the leading private equity investment firms in the country. Since inception, we have managed a series of private equity funds aggregating approximately $4 billion in committed capital. "
target: PharmaNet Development Group, Inc.
PharmaNet Development Group, Inc. is a leader in outsourced clinical development that offers clinical-development solutions including early and late stage consulting services, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs.
price ($mm)[EV]
$101 [$186]
rev ($mm)
$451
EBITDA ($mm)
$26
EV / rev
0.4x
EV / EBITDA
7.1x
closed 1/27/2009 via BusinessWire

Altarum Institute, acquired KAI Research, Inc.

synopsis: Altarum Institute, a non-profit health systems research and consulting organization, has purchased Rockville, Maryland-based KAI Research, Inc. (KAI). KAI provides innovative, cost-effective and practical support to the pharmaceutical and biotech industry, academic institutions and the National Institutes of Health.
buyer: Altarum Institute
Altarum Institute is a nonprofit health systems research and consulting organization serving government and private-sector clients. "
target: KAI Research, Inc.
KAI Research provides innovative, cost-effective and practical support to the pharmaceutical and biotech industries. KAI currently supports pharmaco-vigilance activities for over 90 marketed drugs and is providing safety surveillance for dozens of ongoing clinical trials.
price ($mm)
$7.55
rev ($mm)
$10
EBITDA ($mm)
EV / rev
0.8x
EV / EBITDA
closed 3/13/2009 via BNC Analysis

Premier Research Group, acquired Pivotal Research Centers, LLC

synopsis: PHC, Inc. d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, announced Premier Research Arizona, LLC, a unit of Premier Research Group PLC, has signed a purchase agreement to acquire the assets of PHC's Pivotal Research Centers.
buyer: Premier Research Group
Premier Research is a leading solutions-driven CRO committed to therapeutic focus and operational expertise to deliver clinical trial services of the highest quality for biopharmaceutical and medical device companies. "
target parent: Pioneer Behavioral Health
target: Pivotal Research Centers, LLC
Pivotal Research Centers, LLC provides clinical drug testing. It performs all phases of clinical research for Phase I to Phase IV drugs under development through two research sites. Pivotal was founded by Louis C. Kirby in 1993 and is based in Phoenix, Arizona.
price ($mm)
$3.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/30/2007 via Company Press Release

Chiltern International Inc., acquired Clinical Trial Management Services, Inc.

synopsis: Chiltern, a leading global clinical research organization (CRO), announced the acquisition of Clinical Trial Management Services, Inc. (CTMS) a Bristol, Tennessee based CRO offering high quality services throughout the United States.
buyer: Chiltern International Inc.
Chiltern is a global CRO with experience running and staffing international Phase I to Phase IV clinical trials. Chiltern’s services include: Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions. "
target: Clinical Trial Management Services, Inc.
Clinical Trial Management Services, Inc. provides clinical research services such as clinical trial management and monitoring services, such as project management, investigative site management and monitoring services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/14/2009 via BusinessWire

NexMed, Inc., acquired Bio-Quant, Inc.

synopsis: NexMed, Inc., a developer of products based on the NexACT® technology, announced the closing of its acquisition of Bio-Quant, Inc., a privately-held leading research organization for in vitro and in vivo contract drug discovery and pre-clinical development services, headquartered in San Diego, CA.
buyer: NexMed, Inc. (NEXM:$0.00)
NexMed is an innovative drug developer that is leveraging its proprietary NexACT® drug delivery technology to produce a host of new medical treatments. NexMed’s drugs address a variety of health conditions, such as nail fungus, sexual disorders and more. "
target: Bio-Quant, Inc.
Founded in 1999, Bio-Quant is the largest specialty CRO based in San Diego and is one of the industry's most experienced CROs for in vitro and in vivo pharmacology services and research models specializing in oncology, inflammation, immunology, and metabolic diseases, including diabetes.
price ($mm)[EV]
$13 [$13]
rev ($mm)
$5
EBITDA ($mm)
EV / rev
2.5x
EV / EBITDA
announced 10/28/2009 via PR Newswire

Alpha Analytical, will acquire Boston Analytical

synopsis: Alpha Analytical is announcing the completion of the acquisition of Boston Analytical, Inc. Established in 1987, Boston Analytical is a registered, cGMP compliant contract testing laboratory providing quality analytical and microbiological testing services to the pharmaceutical, biotech, device, cosmetic and nutritional product industries.
buyer: Alpha Analytical
Alpha Analytical, Inc. provides full-service environmental laboratory solutions for the most demanding industrial and commercial applications in the U.S. and abroad. Alpha Analytical is the largest environmental laboratory in New England and among the top 18 laboratories in the country. "
target: Boston Analytical
Boston Analytical is committed to providing quality Analytical and Microbiological testing services to pharmaceutical companies worldwide in support of their Product Development, Release and Stability Testing objectives.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/12/2009 via Company Press Release

J O Hambro Capital Management Limited, acquired Celsis International

synopsis: Chicago-based Celsis International, a leading global life sciences company, announces that it has been acquired by UK-based private equity firm J O Hambro and will de-list from the London Stock Exchange (LSE) and operate as a privately held company.
buyer: J O Hambro Capital Management Limited
J O Hambro Capital Management, the London-based boutique investment firm, offers an alternative to the large traditional fund management firms that have dominated the market for many years. "
target: Celsis International
Celsis International plc is a leading international provider of innovative life science products and laboratory services to the pharmaceutical and consumer products industries through our three divisions: Rapid Detection, Analytical Services and In Vitro Technologies.
price ($mm)[EV]
$55 [$52]*
rev ($mm)
$42
EBITDA ($mm)
$12
EV / rev
1.9x
EV / EBITDA
6.3x
closed 7/16/2009 via PR Newswire

Water Street Healthcare Partners, acquired AAIPharma Services

synopsis: Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, announced that it has acquired the Pharmaceutical Development division from AAIPharma Inc.
buyer: Water Street Healthcare Partners
Water Street Healthcare Partners is a leading private equity firm focused exclusively on health care. With more than $1 billion of capital under management, Water Street is one of the most active investors in the health care industry. "
target parent: AAIPharma Inc.
target: AAIPharma Services
AAIPharma Services serves more than 300 large pharmaceutical and biotechnology companies. Its team of 450 scientists and professionals specialize in services that encompass the entire process of pharmaceutical drug development from discovery through commercialization.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 6/1/2009 via Reuters

INC Research, Inc., will purchase Late Stage Research Unit from MDS, Inc.

synopsis: MDS Inc has announced that it planns to narrow its contract research focus by selling its late stage operations and central laboratory divisions to Contract Research Organization INC Research, Inc.
buyer: INC Research, Inc. (SYNH:$3,472.40)
INC Research is a therapeutically focused contract research organization with an unrivaled reputation for conducting Phase I- Phase IV clinical development programs of the highest integrity. "
seller: MDS, Inc. (MDZ:$231.00)
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
price ($mm)
$45
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/17/2009 via PR Newswire

ChemRar High-Tech Center, acquired Prudentas, LLC

synopsis: ChemDiv, a global chemistry-driven contract research organization, announced that its ChemRar High Tech Center has acquired Prudentas LLC, one of the leading CRO companies conducting high quality Phase I - Phase IV studies in Eastern Europe.
buyer parent: ChemDiv, Inc.
buyer: ChemRar High-Tech Center
The ChemRar High-Tech Center is a unique pharma and biotechnology complex founded by innovative life science organizations in Russia. ChemRar's component companies are engaged in discovering, developing and commercializing novel drugs for partners in Russia and worldwide. "
target: Prudentas, LLC
Prudentas is a Russian Clinical Contract Research Organization founded by and consisting of highly qualified clinical research professionals with extensive experience of working previously together as a team.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2014 via BusinessWire

Quintiles Transnational Corp., acquired Encore Health Resources

synopsis: Quintiles announced that it has completed the acquisition of Encore Health Resources, a leader in the health-information analytics and technology consulting services industry focused on healthcare providers.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. "
target: Encore Health Resources
Encore Health Resources provides world-class industry experts to the healthcare market who have specialized knowledge of the industry’s major clinical and business applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/19/2011 via BusinessWire

Quintiles Transnational Corp., acquired VCG

synopsis: Quintiles announced the acquisition of VCG & Associates and VCG BIO ("VCG"), based in Holliston, Mass., and Cave Creek, Ariz., respectively. The addition of VCG strengthens Quintiles’ comprehensive commercial services in sales and brand solutions, product solutions, product distribution and market access.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. "
target: VCG
VCG develops strategic healthcare marketing initiatives to address the challenges surrounding U.S. pharmaceutical market entry. It focuses on biopharma companies that need supplemental resources to maximize commercial opportunities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/7/2008 via PR Newswire

Quintiles Transnational Corp., will acquire Eidetics

synopsis: Quintiles Transnational Corp. announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics and market research consulting firm located in Boston as part of its expanding Quintiles Consulting business.
buyer: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the only fully integrated bio and pharmaceutical services provider offering clinical, commercial, consulting and capital solutions. Our 23,000 employees in more than 50 countries have helped develop or commercialize all of the top 30 best-selling drugs. "
target: Eidetics
Eidetics is being acquired by Quintiles. A market research and consulting company serving the world's leading pharmaceutical, biotechnology, and medical device companies. Headquartered in Boston, we have extensive international resources to address the global nature of today's marketing challenges.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/13/2019 via BNC Analysis

IQVIA, acquired Linguamatics Limited

synopsis: Health analytics and contract research heavyweight IQvia has acquired bioinformatics company Linguamatics. Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text.
buyer: IQVIA (NYSE:IQV:$10,412.00)
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. "
target: Linguamatics Limited
Linguamatics delivers market-leading Natural Language Processing (NLP) based AI solutions for high-value knowledge discovery and decision support from text. They empower their customers to speed up drug development and improve patient outcomes.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/17/2017 via BusinessWire

eMids Technologies, acquired Encore Health Resources

synopsis: emids, a rapidly growing global provider of IT services and solutions for the healthcare and life sciences industries, announced the acquisition of Encore Health Resources, a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
buyer: eMids Technologies
emids is a premier provider of healthcare IT services and solutions. emids enables healthcare entities to achieve accessible, affordable and high-quality care by providing custom application and data solutions. "
target parent: QuintilesIMS
target: Encore Health Resources
Encore Health Resources is a leading healthcare information analytics company focused on value-based care and electronic health records for providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/25/2016 via BusinessWire

IMS Health Incorporated, acquired Privacy Analytics

synopsis: IMS Health has acquired Privacy Analytics Incorporated. Privacy Analytics offers an innovative suite of data governance software and advisory services that enable stakeholders to optimize benefits of the growing volume and availability of new, complex datasets while protecting patient privacy.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. IMS Health uses anonymous healthcare data to deliver critical, real-world disease and treatment insights. "
target: Privacy Analytics
Privacy Analytics enables healthcare organizations to quickly and easily apply a risk-based responsible de-identification methodology that ensures individual privacy and legal compliance. They offer expert training, software, methodology and services that protect the privacy of individuals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/3/2016 via BusinessWire

Quintiles Transnational Corp. merged with IMS Health Incorporated,

synopsis: Quintiles IMS Holdings, Inc. announced that it has successfully completed its merger of equals transaction between IMS Health Holdings, Inc. and Quintiles Transnational Holdings Inc. The merger creates a leading information and tech-enabled global healthcare service provider, and a full suite of end-to-end clinical and commercial offerings.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Quintiles Transnational Corp. (Q:$4,497.17)
Quintiles is the world’s largest provider of biopharmaceutical development services and commercial outsourcing services. They help customers navigate the increasingly complex healthcare environment to improve efficiency and to deliver better healthcare outcomes.
price ($mm)
$8,750
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/4/2016 via BusinessWire

IMS Health Incorporated, acquired Dimensions Healthcare, LLC

synopsis: IMS Health, a leading global provider of information and technology services to the healthcare and life sciences industries, announced completion of its acquisition of Dimensions Healthcare, a United Arab Emirates (UAE) company which provides high quality healthcare systems to payers, providers and regulatory bodies.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target: Dimensions Healthcare, LLC
Dimensions Healthcare (“Dimensions”) is a leading developer of healthcare informatics solutions that assist private and public sectors to offer higher-quality healthcare services by collecting and processing information that is used to decrease inefficiencies and reduce wasteful expenditures.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/3/2016 via PR Newswire

IMS Health Incorporated, acquired AlphaImpactRx, Inc

synopsis: Symphony Technology Group announced the closing of the sale of AlphaImpactRx, a leading provider of primary research and analytics-based insight for biopharmaceutical and consumer health companies to IMS Health, a global information and technology services company serving the healthcare industry.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with end-to-end solutions to measure and improve their performance. They connect configurable SaaS applications to complex healthcare data in the IMS One™ cloud platform. "
target parent: Symphony Technology Group
target: AlphaImpactRx, Inc
AlphaImpactRx is the leading provider of primary research-based insights, analytics and solutions to pharmaceutical, consumer health and medical device companies. They provide market research to help its global healthcare clients make informed and business decisions to market their products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2015 via BNC Analysis

IMS Health Incorporated, acquired IASIST, S.A.

synopsis: IMS Health, a leading global information and technology services company, has acquired IASIST, an added value, professional service company which offers health care providers, payers and the health industry the clinical and economic information required to improve quality and efficiency in their organizations.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: IASIST, S.A.
Iasist is an added value, professional service company which offers health care providers, payers and the health industry the clinical and economic information required to improve quality and efficiency in their organisations and the services provided to their customers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/6/2015 via BusinessWire

IMS Health Incorporated, acquired Dataline Software

synopsis: IMS Health has acquired Dataline Software, a leader in Big Data analytics for healthcare. U.K.-based Dataline has worked closely with life sciences companies, payers, healthcare authorities and academia to deliver tailored software for rapid analysis and elegant visualizations of large, complex healthcare data sets.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is an information and technology services company providing clients in the healthcare industry with solutions to measure and improve their performance. The company's IMS One™ cloud platform provides comprehensive insights into diseases, treatments, costs and outcomes. "
target: Dataline Software
Dataline is a software solutions company specializing in big-data analytics solutions for healthcare. They also provide consultancy, training, system implementation, application development and technical support to a wide and varied client base.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/1/2015 via BusinessWire

IMS Health Incorporated, purchased CRM and Strategic Data Division from Cegedim

synopsis: IMS Health, a leading global provider of information and technology services to the healthcare and life sciences industries, completed its acquisition of certain customer relationship management (CRM) and strategic data businesses of Cegedim, a global technology and services company specializing in healthcare.
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance. The company connects complex healthcare data on diseases, treatments, costs and outcomes. "
seller: Cegedim (ENXTPA:CGM:$512.82)
Cegedim is a global technology and services company specializing in healthcare. Cegedim’s CRM solutions help Life Sciences and Healthcare clients in 80 countries drive sales effectiveness, optimize marketing programs across multiple channels and mitigate regulatory compliance risks.
price ($mm)
$523
rev ($mm)
$584
EBITDA ($mm)
$88
EV / rev
0.9x
EV / EBITDA
5.9x
closed 5/8/2014 via BusinessWire

IMS Health Incorporated, acquired Forcea

synopsis: IMS Health has acquired Forcea, a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Forcea
Forcea is a leading Belgium-based provider of business intelligence applications and analytics, to advance performance management capabilities for hospitals and life sciences organizations around the globe.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/9/2013 via BusinessWire

IMS Health Incorporated, acquired Pygargus

synopsis: IMS Health, a leading worldwide provider of information, technology and services, has acquired Pygargus, an industry-leading life sciences advisory and analytics firm based in Sweden, to further advance its technology-enabled Real-World Evidence solutions and global RWE footprint.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Pygargus
Pygargus is a leading independent Scandinavian life science consultancy specialized in Real World Outcomes Research, offering expertise in electronic medical records, registry data handling, data integration and scientific project management.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 8/15/2013 via BNC Analysis

IMS Health Incorporated, will acquire Diversinet Corp.

synopsis: Toronto-based mobile health company Diversinet agreed to sell its assets to subsidiaries of Parsippany, New Jersey-based IMS Health for about $3.5 million. The sale includes Diversinet’s intellectual property, software, and customer contracts. IMS Health is a leading worldwide provider of healthcare information, technology, and services.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Diversinet Corp. (US:DVNTF:$1.51)
Diversinet provides its customers and partners with ultra-secure, patented mobile technologies and connected health solutions. Its core multilingual publishing platform supports rapid deployment of secure and HIPAA-compliant Web-to-mobile applications.
price ($mm)
$1.75
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/6/2013 via BusinessWire

IMS Health Incorporated, acquired Incential Software, Inc.

synopsis: IMS Health has acquired Incential Software, an industry-leading Software-as-a-Service company based in Raleigh, NC, to advance its sales performance management capabilities for life sciences organizations worldwide. Incential delivers technology & services that integrate incentive compensation, data management, & business intelligence applications.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Incential Software, Inc.
Incential Software is a leading provider of sales performance management software and services to pharmaceutical, biotech and medical device companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 5/20/2013 via BusinessWire

IMS Health Incorporated, acquired 360 Vantage

synopsis: IMS Health announced the acquisition of 360 Vantage, a leading provider of cloud-based multi-channel CRM and closed loop marketing technologies, to further extend its commercial Software-as-a-Service capabilities for life sciences and healthcare organizations around the globe.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: 360 Vantage
Established in 2005 and headquartered in Chandler, Arizona, 360 Vantage is a leader in cloud-based mobile sales and marketing systems designed to solve the more complex front office challenges in Life Sciences and Healthcare.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/30/2013 via BusinessWire

IMS Health Incorporated, acquired Semantelli

synopsis: IMS Health announced the acquisition of Semantelli Corporation, a Bridgewater, N.J.-based social media analytics company, to extend its marketing and consumer engagement capabilities for healthcare organizations around the world. Semantelli offers cloud-based tools that automate the collection of healthcare-specific social media content.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is a leading worldwide provider of information, technology, and services dedicated to making healthcare perform better. The IMS global technology infrastructure, advanced analytics and proprietary software platforms help clients improve patient outcomes and operate more efficiently. "
target: Semantelli
Semantelli’s solutions for global life sciences and healthcare companies address compliance needs in social media, guide marketing activities and identify new real-time opportunities with insights gleaned from social media.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/12/2013 via Yahoo, Inc.

IMS Health Incorporated, acquired Appature

synopsis: IMS Health has acquired Appature, a leading Software-as-a-Service (SaaS) company based in Seattle. Appature offers clients a cloud-based relationship marketing platform to address the complexities of today’s multi-stakeholder healthcare environment, and to enable the measurement and optimization of relationship marketing programs across channels.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Ignition Partners
target: Appature
Appature is a Seattle-based technology company that provides cloud-based marketing solutions designed exclusively for healthcare companies. Leaders in the pharmaceutical, medical device, and health and wellness industries rely on Appature to realize the true potential of their marketing efforts
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/15/2012 via BusinessWire

IMS Health Incorporated, acquired TTC LLC

synopsis: IMS Health has acquired TTC, a Philadelphia-based benchmarking solutions and analytics company that helps life sciences organizations around the world plan for and negotiate the costs of clinical trials. TTC offers clients a robust set of clinical trial cost benchmarks, budgeting and negotiation tools.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: TTC LLC
TTC is the leader in global clinical trial cost benchmarking. With offices in Philadelphia, TTC has a proven track record in all aspects of outsourcing cost management, from the budgeting of protocols and clinical trials to negotiations with clinical sites and other providers.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/14/2012 via BusinessWire

IMS Health Incorporated, acquired PharmaDeals Ltd.

synopsis: IMS Health announced the acquisition of PharmaDeals Ltd., a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global pharmaceutical industry. PharmaDeals maintains a web-based subscription database containing more than 46,000 records of industry transactions.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: PharmaVentures Ltd.
target: PharmaDeals Ltd.
PharmaDeals Ltd. is a market-leading provider of online information about business transactions, licensing, and mergers & acquisitions activity within the global pharmaceutical industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/24/2012 via BusinessWire

IMS Health Incorporated, acquired DecisionView, Inc.

synopsis: IMS Health has acquired DecisionView, a software solutions company that helps life sciences organizations plan and track patient enrollment for clinical trials around the world. DecisionView offers its clients an innovative suite of decision support tools to improve the speed, efficiency and performance of clinical trial planning and management.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target parent: Granite Ventures, LLC
target: DecisionView, Inc.
DecisionView develops web-based software solutions that enable life sciences organizations around the world to improve clinical trial performance. Its flagship solution, StudyOptimizer®, is a web-based solution that helps clinical trial organizations plan, forecast and track patient enrollment.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/24/2012 via BusinessWire

IMS Health Incorporated, acquired PharmARC Analytic Solutions Pvt. Ltd.

synopsis: IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry. The acquisition adds significant scale to a world-class services delivery platform, strengthens IMS’s business process outsourcing capabilities.
buyer parent: TPG Capital
buyer: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the leading provider of information services for the healthcare industry around the world. The company draws on its global technology infrastructure and unique combination of in-depth, analytics, and consulting platforms to help clients better understand the value of medicines. "
target: PharmARC Analytic Solutions Pvt. Ltd.
PharmARC is a leading provider of analytic solutions for the efficient commercialization of drugs and medical products. The firm’s analytics and services enable its life sciences customers to make informed decisions related to their sales and marketing strategies and implementation.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/5/2010 via Company Press Release

CPP Investment Board, TPG Capital, acquired IMS Health Incorporated

synopsis: IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, announced the completion of its acquisition by entities created by certain affiliates of TPG Capital, L.P. (“TPG”) and the CPP Investment Board (“CPPIB”).
buyer: CPP Investment Board
buyer: TPG Capital
TPG is a leading global private investment firm with approximately $45 billion of capital under management across a family of funds. TPG's investment philosophy has been to create value by investing in change - change created by industry trends, economic cycles or specific company circumstances. "
target: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations.
price ($mm)[EV]
$4,014 [$5,057]
rev ($mm)
$2,171
EBITDA ($mm)
$489
EV / rev
2.3x
EV / EBITDA
10.4x
announced 7/7/2008 via PR Newswire

Signalife, Inc., will acquire Heart One Global Research

synopsis: Signalife, Inc. and Heart One Global Research, an Irish-based heart information and clinical information management concern -- with technology used across the world through subsidiaries and affiliates in eight different countries have agreed to merge or consummate a similar business combination making them one company.
buyer: Signalife, Inc. (SGN:$0.00)
Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. "
target: Heart One Global Research
Heart One Global is the London-based international developer and distributor of information technologies that are clinically focused, mature, stable, robust, comprehensive, flexible, portable, and standards-based electronic health record solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/20/2007 via BusinessWire

Elsevier Business Information, acquired Clinical Practice Model Resource Center, Inc.

synopsis: Elsevier, the world's leading publisher of science and health information, has purchased CPM Resource Center from Eclipsys, a leading provider of integrated enterprise clinical, revenue cycle, access management, and decision support solutions. CPM Resource Center is a leading provider of executable evidence-based clinical tools.
buyer parent: Reed Elsevier plc
buyer: Elsevier Business Information
Elsevier is a world-leading publisher of scientific, technical and medical information products and services. Working in partnership with the global science and health communities, Elsevier’s 7,000 employees in over 70 offices worldwide publish more than 2,000 journals and 1,900 new books per year. "
target parent: Eclipsys Corporation
target: Clinical Practice Model Resource Center, Inc.
CPM Resource Center’s evidence-based products and professional services assist healthcare organizations in creating a healthy work culture and interdisciplinary integration using a professional practice framework and standardization.
price ($mm)
$25
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/19/2007 via BusinessWire

Healthnostics, Inc., acquired MedNets, Inc.

synopsis: Healthnostics, Inc. a medical and biotechnology analytics company, today announced the completion of the MedNets.com acquisition, an Internet portal providing healthcare information resources to consumers and professionals.
buyer: Healthnostics, Inc. (OTCPK:HNSS:$0.20)
Healthnostics, Inc. is a medical and biotechnology analytics company that provides patient clinical monitoring and risk management systems to acute care hospitals, and utilizes its Internet portals to deliver medical and biotechnology resource information. "
target: MedNets, Inc.
MedNets, Inc. offers MedExplore, our medical professional and patient Healthcare Information Directory, through our web site. We have gathered over 20,000 healthcare links in our directory, creating the source to the finest medical information on the Internet.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/26/2007 via PR Newswire

ConnectivHealth, acquired Relegent

synopsis: ConnectivHealth today announced it has acquired Relegent, a Nashville, Tenn.--based provider of health care information to the hospital and education industries. Terms of the deal were not disclosed.
buyer parent: Chrysalis Ventures
buyer: ConnectivHealth
ConnectivHealth is building a network of health care information and new media businesses that enable the delivery, distribution, and organization of important health information for physicians, health care professionals, hospitals, and consumers. "
target: Relegent
Relegent is a leading health care information and marketing firm based in Nashville. Relegent owns and operates HealthTeacher, the leading K-12 online health curriculum. The company also exclusively markets Discovery Hospital content to hospitals.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/18/2007 via BusinessWire

MCF Corporation, acquired MedPanel, Inc.

synopsis: MCF Corporation has completed the acquisition of MedPanel, Inc., an online medical market intelligence firm. With the closing of the transaction, MedPanel, Inc. becomes Panel Intelligence, LLC, a wholly owned subsidiary of MCF Corporation.
buyer: MCF Corporation (MEM:$0.00)
MCF Corporation is a financial services holding company that provides investment research, capital markets services, corporate and venture services, investment banking, asset management and wealth management through its operating subsidiaries. "
target: MedPanel, Inc.
MedPanel provides online medical market intelligence to the life sciences industry through custom research and syndicated studies. Research services include study design, recruitment, programming, panel moderation, advanced data analysis and summaries.
price ($mm)
$7.00
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/16/2006 via PR Newswire

Medstat, acquired Solucient LLC

synopsis: The Thomson Corporation, a leading provider of information to professional customers worldwide, has completed the acquisition of Solucient, LLC, a healthcare information business. Terms of the deal were not disclosed.
buyer parent: The Thomson Corporation
buyer: Medstat
Thomson Medstat provides healthcare information services – databases, software applications, analytic consulting, and research services – to all sectors of the healthcare industry. "
target parent: The Nielsen Company, Inc.
target: Solucient LLC
Solucient is an information products company serving the healthcare industry. It is a leader in providing tools and vital insights that healthcare managers use to improve the performance of their organizations.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/19/2006 via Company Press Release

Reed Elsevier plc, acquired Gold Standard Multimedia

synopsis: Elsevier, a world-leading healthcare and scientific publisher, announced today that it has entered into a definitive agreement to acquire the entire share capital of Gold Standard, Inc., a US-based developer of online clinical drug information products, services and solutions to the healthcare market.
buyer: Reed Elsevier plc (LSE:REL:$10,030.06)
Reed Elsevier is a world leading publisher and information provider. Operating in the scientific, medical, legal, risk and business-to-business sectors, Reed Elsevier provides high value and flexible information solutions to professional end users, with increasing emphasis on internet delivery. "
target: Gold Standard Multimedia
A privately-held company founded in 1993, Tampa, Florida-based Gold Standard Multimedia (GSM) is a leading developer of innovative medical education and drug information software, online services and e-learning solutions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/20/2005 via BNC Analysis

EBSCO Publishing, Inc., acquired DynaMed, LLC

synopsis: Expanding its presence in the medical arena, EBSCO Publishing (http://www.ebsco.com) announced the acquisition of DynaMed (http://www.dynamicmedical.com), an evidence-based clinical reference tool developed by a physician.
buyer parent: EBSCO Industries, Inc.
buyer: EBSCO Publishing, Inc.
EBSCO Publishing is the world's premier database aggregator, offering a suite of nearly 300 full-text and secondary research databases. EBSCO serves the content needs of all researchers: Academic, Medical, K-12, Public Library, Corporate, Government. "
target: DynaMed, LLC
DynaMed is a point-of-care reference resource designed to provide doctors and medical researchers with the best available evidence to support clinical decision-making.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/14/2005 via PR Newswire

National Care Network, Inc., acquired Data Advantage Corporation

synopsis: National Care Network (NCN) has completed the acquisition of Data Advantage Corporation, a leading healthcare information company. The acquisition combines NCN's recognized cost control services with Data Advantage's strategic products and information.
buyer: National Care Network, Inc.
NCN is a privately owned healthcare cost management firm established in 1994 by medical claims experts. NCN is an industry leader in providing highly effective cost control services to all types of medical claims payors across the United States. NCN's proactive approach of on-going two way communica"
target: Data Advantage Corporation
Data Advantage Corporation is a healthcare information company. The company specializes in providing the healthcare, business and financial community a cost effective source for reliable and timely healthcare information products and services.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
cancelled 11/17/2005 via BusinessWire

VNU nv, cancelled an acquisition of IMS Health Incorporated

synopsis: VNU NV announced it has agreed with IMS Health, Inc. to terminate the planned merger of the two companies. VNU said the two companies decided to call off their merger after shareholders claiming to represent nearly 50% of VNU's outstanding shares said they would not support the transaction under any circumstances.
buyer parent: Valcon Acquisition BV
buyer: VNU nv (NLSN:$6,465.00)
The Nielsen Company is world’s leading provider of marketing information, audience measurement, and business media products and services. Nielsen provides clients with the most complete view of their consumers and their markets. "
target: IMS Health Incorporated (NYSE:IQV:$10,412.00)
IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations.
price ($mm)
$7,000
rev ($mm)
$1,569
EBITDA ($mm)
$517
EV / rev
4.5x
EV / EBITDA
13.5x
closed 3/14/2018 via PR Newswire

BioInformatics Inc., acquired IMV Ltd.

synopsis: BioInformatics Inc., the leading market research firm supporting the analytical instrumentation and life science industries, and owner of The Science Advisory Board, has acquired IMV Publishing, a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets.
buyer: BioInformatics Inc.
BioInformatics Inc. is the leading research and advisory firm serving the life science, diagnostic and analytical instrument industries. Their expertise includes assessing the size and attractiveness of markets, optimizing product configurations and pricing and validating corporate acquisitions. "
target: IMV Ltd.
IMV Publishing is a recognized leader in market research and online publishing for the medical imaging and clinical diagnostic instruments markets. IMV’s complete line of research reports provides decision makers with site-specific databases and comprehensive market reports.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/7/2013 via PR Newswire

Wolters Kluwer Health, acquired Health Language Inc.

synopsis: Wolters Kluwer Health, a leading provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy, announced that it has completed the acquisition of Health Language, Inc., a leader in the fast-growing Medical Terminology Management (MTM) market.
buyer parent: Wolters Kluwer NV
buyer: Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Its customers include professionals, institutions and students in medicine, nursing, allied health and pharmacy. "
target: Health Language Inc.
Health Language, Inc. specializes in the development, delivery and marketing of software that reduces the complexity of incorporating medical vocabulary and coding standards into healthcare information technology (HCIT) applications.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2010 via Market Wire

TransUnion LLC, acquired MedData

synopsis: TransUnion announced it acquired MedData LLC. The Charlotte-based company provides healthcare insurance information and data solutions for hospitals, physician practices and major healthcare insurance companies. Financial terms of the deal were not disclosed.
buyer: TransUnion LLC (TRU:$2,399.10)
TransUnion is a global leader in credit and information management. The company creates advantages for millions of people around the world by gathering, analyzing and delivering information. For businesses TransUnion delivers comprehensive data and advanced analytics. "
target parent: AGData
target: MedData
MedData is the healthcare division of AGDATA, L.P. MedData was formed to apply and use state-of-the-art database and real-time transaction processing technology for the healthcare industry.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 10/14/2008 via BusinessWire

Health Grades, Inc., acquired Adviware Pty. Ltd.

synopsis: Health Grades, Inc., the leading healthcare ratings company, announces the acquisition of WrongDiagnosis.com, a highly trafficked health information and community Web site. WrongDiagnosis.com was owned by Adviware Pty. Ltd., a privately held company based in Australia.
buyer: Health Grades, Inc. (HGRD:$58.17)
Health Grades, Inc. is the leading healthcare ratings organization, providing ratings and profiles of hospitals, nursing homes and physicians. Millions of patients and many of the nation’s largest employers, health plans and hospitals rely on HealthGrades’ independent ratings and advisory services. "
target: Adviware Pty. Ltd.
Adviware Pty. Ltd owns and operats WrongDiagnosis.com,which includes symptoms, diagnosis and treatment information including a database of statistics and cross-referenced medical information, tools and community forums covering more than 11,000 conditions and treatments.
price ($mm)[EV]
$6.24 [$4.41]
rev ($mm)
$2
EBITDA ($mm)
$1
EV / rev
3.9x
EV / EBITDA
7.2x
closed 4/11/2006 via PR Newswire

Workplace Options, acquired HelpHorizons.com, Inc.

synopsis: Workplace Options, the largest provider of work-life employee benefits in America, today announced the acquisition of HelpHorizons.com, Inc., the country's leading provider of practice management and connectivity solutions for mental health professionals and behavioral health organizations.
buyer: Workplace Options
Workplace Options (WPO) is America's largest provider of work-life services and software that help EAPs and other third-parties run their business more profitably and efficiently. "
target: HelpHorizons.com, Inc.
Dedicated to providing innovative services and information to consumers and mental health professionals. We offer the largest mental health professional referral database online today and technology that supports secure, private e-counseling via e-mail, chat rooms, or videoconferencing.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/17/2013 via PR Web

Healthcare Data Solutions, acquired StratCenter

synopsis: Healthcare Data Solutions, a leading provider of healthcare databases, compliance and business intelligence services, announced the acquisition of StratCenter®, an established leader, delivering the most comprehensive provider facility databases and sales solutions available to the supply chain.
buyer: Healthcare Data Solutions
Healthcare Data Solutions is a leading healthcare information services company focused on building and maintaining the most accurate, compliance-grade data on Physicians, Dentists, Nurse Practitioners and other Healthcare Providers, as well as Pharmacies and Hospitals. "
target: StratCenter
StratCenter was founded in 2002 to provide the healthcare industry with a single point of access to the latest industry news, and to the most comprehensive sets of public and privately-held data on hospitals, IDNs, GPOs, and provider groups.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/8/2020 via BusinessWire

Press Ganey Associates, Inc., acquired Strategic Management Decisions

synopsis: Press Ganey has announced its acquisition of Strategic Management Decisions (SMD), a leading health care HR consulting and predictive analytics company. SMD’s proprietary technology enables health systems to optimize their talent acquisition and talent management efforts and realize measurable improvements in key HR performance metrics.
buyer: Press Ganey Associates, Inc. (PGND:$344.32)
Press Ganey offers an integrated suite of solutions that enables enterprise transformation across the patient journey. Delivered through a cutting-edge digital platform, Press Ganey solutions address safety, clinical excellence, patient experience, and workforce engagement. "
target: Strategic Management Decisions
Strategic Management Decisions (SMD) is a leading health care HR consulting and predictive analytics company. SMD’s proprietary technology enables health systems to optimize their talent acquisition and talent management efforts and realize measurable improvements in key HR performance metrics.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/6/2019 via PE Hub

Catalyst Clinical Research, LLC, acquired Tri Stat

synopsis: Catalyst Clinical Research, LLC, a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies, has acquired Triangle Biostatistics, LLC (Tri Stat), a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry.
buyer parent: NovaQuest
buyer: Catalyst Clinical Research, LLC
Catalyst Clinical Research is a leading provider of clinical operation solutions to the biotechnology, pharmaceutical and medical device companies. The company assists clients with their clinical development programs by providing therapeutically-aligned experts and teams and customized solutions. "
target: Tri Stat
Triangle Biostatistics (Tri Stat) is a leading provider of statistical programming, statistical consulting, and data management services for the pharmaceutical industry. Tri Stat provides strong statistical consulting and programming support utilizing the latest computing technology.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 6/13/2018 via Company Press Release

Bertram Capital Management LLC, acquired Registrar Corp

synopsis: Bertram Capital announced its investment in Registrar, LLC, a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
buyer: Bertram Capital Management LLC
Bertram Capital is a private equity firm targeting investments in lower middle market companies. By supplying flexible investment capital and committing a wealth of operational and strategic resources, they make their core objective to move companies toward unlocking their full potential. "
target: Registrar Corp
Registrar Corp is a leading SaaS assisted provider of U.S. Food and Drug Administration (“FDA”) compliance services to domestic and foreign food, medical device, drugs, and cosmetic facilities.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like Quintiles Transnational Corp.


read more

Quintiles Transnational Corp.

Invicro, LLC

Aptuit, Inc.

PAREXEL International Corporation

inVentiv Health, Inc.

Excel PharmaStudies Inc.

Encorium Group Inc.

Clinical Trials of the Americas, Inc.

Ockham Development Group, Inc.

AbCRO, Inc.

PharmaNet Development Group, Inc.

KAI Research, Inc.

Pivotal Research Centers, LLC

Clinical Trial Management Services, Inc.

Bio-Quant, Inc.

Boston Analytical

Celsis International

AAIPharma Services

MDS, Inc.

Prudentas, LLC

read more

Encore Health Resources

Quintiles Transnational Corp.

Encore Health Resources

VCG

Eidetics

read more

Linguamatics Limited

Encore Health Resources

Privacy Analytics

Quintiles Transnational Corp.

Dimensions Healthcare, LLC

AlphaImpactRx, Inc

IASIST, S.A.

Dataline Software

Cegedim

Forcea

Pygargus

Diversinet Corp.

Incential Software, Inc.

360 Vantage

Semantelli

Appature

TTC LLC

PharmaDeals Ltd.

DecisionView, Inc.

PharmARC Analytic Solutions Pvt. Ltd.

read more

IMS Health Incorporated

Heart One Global Research

Clinical Practice Model Resource Center, Inc.

MedNets, Inc.

Relegent

MedPanel, Inc.

Solucient LLC

Gold Standard Multimedia

DynaMed, LLC

Data Advantage Corporation

IMS Health Incorporated

IMV Ltd.

Health Language Inc.

MedData

Adviware Pty. Ltd.

HelpHorizons.com, Inc.

StratCenter

Strategic Management Decisions

Tri Stat

Registrar Corp

Geography
Matching Companies
Ticker: SYNH
 
 
 
 
 
 
 
 
INC Research, Inc.
INC Research, Inc.
INC Research is a leading global contract research organization ("CRO") providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries.
year
2018
rev ($mm)
$3,472.40
EBITDA ($mm)
$441.82
EBIT ($mm)
$157.52
Net Income ($mm)
Employees
21000
  • drill down
  • watch
Ticker: ICLR
 
 
 
 
 
 
 
 
ICON Plc
ICON Plc
ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development.
year
2015
rev ($mm)
$1,541.91
EBITDA ($mm)
$289.74
EBIT ($mm)
$234.82
Net Income ($mm)
$192.14
Employees
11200
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
CMIC Co., Ltd.
CMIC is a leading full-service CRO in Japan offering a wide range of services in clinical trials in Asia to both multi-national and Japanese pharma companies.
year
2019
rev ($mm)
$664.65
EBITDA ($mm)
$76.21
EBIT ($mm)
$43.15
Net Income ($mm)
$23.12
Employees
4962
  • drill down
  • watch
Ticker: PIELF
 
 
 
 
 
 
 
 
Pierrel SpA
Pierrel SpA
Pierrel S.p.A. is a pharmaceutical company specializing in contract research, development and the manufacture of medicines. The Pierrel Group boasts over 50 years of experience in the pharmaceutical sector, and is one of the main Italian manufacturers of local anaesthetics for dental use.
year
2008
rev ($mm)
$64.38
EBITDA ($mm)
($4.23)
EBIT ($mm)
($8.92)
Net Income ($mm)
Employees
504
  • drill down
  • watch
Ticker: ENCO
 
 
 
 
 
 
 
 
Encorium Group Inc.
Encorium is a full-service Contract Research Organization providing comprehensive solutions for pharmaceutical, biotechnology, and medical device companies. At Encorium we recognize the challenges that often arise during drug development.
year
2008
rev ($mm)
$35.91
EBITDA ($mm)
($5.19)
EBIT ($mm)
($6.89)
Net Income ($mm)
Employees
226
  • drill down
  • watch
Ticker: ENXTPA:ERF
 
 
 
 
 
 
 
 
Eurofins Group
Eurofins Group
Based in Luxembourg, Eurofins is a leading international group of laboratories providing a unique range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments.
year
2019
rev ($mm)
$5,244.00
EBITDA ($mm)
$922.65
EBIT ($mm)
$524.54
Net Income ($mm)
$224.34
Employees
47427
  • drill down
  • watch
Ticker: CRL
 
 
 
 
 
 
 
 
Charles River Laboratories International Inc.
Charles River Laboratories International Inc.
Charles River has been helping our global partners accelerate drug discovery and development by providing them with tailored research models and preclinical, clinical, support services.
year
2009
rev ($mm)
$1,202.55
EBITDA ($mm)
$282.48
EBIT ($mm)
$188.93
Net Income ($mm)
$114.44
Employees
8000
  • drill down
  • watch
Ticker: LH
 
 
 
 
 
 
 
 
LabCorp
LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialty testing laboratories. LabCorp processes tests on approximately 470,000 specimens each day, applying advances in medicine and science to laboratory testing.
year
2009
rev ($mm)
$4,694.70
EBITDA ($mm)
$1,142.70
EBIT ($mm)
$949.40
Net Income ($mm)
$543.30
Employees
28000
  • drill down
  • watch
Ticker: NYSE:IQV
 
 
 
 
 
 
 
 
IQVIA
IQVIA
IQVIA Holdings Inc. provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services.
year
2018
rev ($mm)
$10,412.00
EBITDA ($mm)
$1,950.00
EBIT ($mm)
$809.00
Net Income ($mm)
$259.00
Employees
58000
  • drill down
  • watch
Ticker: TSE:2413
 
 
 
 
 
 
 
 
M3, Inc.
M3 Inc. represents the three Ms of Medicine, Media, and Metamorphosis. Their company was founded with the goal of changing the world of medicine through making full use of the power of the Internet.
year
2019
rev ($mm)
$1,127.03
EBITDA ($mm)
$319.84
EBIT ($mm)
$286.78
Net Income ($mm)
$193.56
Employees
6024
  • drill down
  • watch
Ticker: TSE:4483
 
 
 
 
 
 
 
 
JMDC Inc.
JMDC Inc.
JMDC Inc. offers information services. The Company provides medical data statistics, life insurance data statistics, health data platform management, and other services. JMDC provides its services throughout Japan.
year
2019
rev ($mm)
$91.75
EBITDA ($mm)
EBIT ($mm)
$13.68
Net Income ($mm)
$9.40
Employees
441
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Clarivate Analytics
Clarivate Analytics
Clarivate Analytics is a research analytics software company that provides subscription-based services in research and patent analytics. Organizations and researchers rely on the knowledge bases from Clarivate for information about pharmaceutical and biotech intelligence and IP management.
year
2019
rev ($mm)
$964.58
EBITDA ($mm)
$154.61
EBIT ($mm)
($47.97)
Net Income ($mm)
Employees
4515
  • drill down
  • watch
Ticker: ENXTPA:CGM
 
 
 
 
 
 
 
 
Cegedim
Cegedim
Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases.
year
2018
rev ($mm)
$512.82
EBITDA ($mm)
$50.20
EBIT ($mm)
$33.91
Net Income ($mm)
$6.33
Employees
4468
  • drill down
  • watch
Ticker: PBSV
 
 
 
 
 
 
 
 
Pharma-Bio Serv Inc.
PharmaBio Serv offers a full range of Regulatory Compliance Quality Systems, Validation & Qualification Services and Technology Transfer based on the latest FDA guidelines, as well as day to day process support.
year
2008
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:MDCL
 
 
 
 
 
 
 
 
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc. was established in March 2014. They have provided guidance for several clients that have successfully secured licenses to operate cannabis businesses within their state.
year
2016
rev ($mm)
$0.82
EBITDA ($mm)
($0.18)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
4
  • drill down
  • watch
Ticker: OTCPK:NBGV
 
 
 
 
 
 
 
 
NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc.
NewBridge Global Ventures, Inc. is a US public company which provides business consulting services to companies operating within the legal medical cannabis and hemp related industries.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($4.16)
Net Income ($mm)
Employees
14
  • drill down
  • watch
Ticker: LSE:UDG
 
 
 
 
 
 
 
 
UDG Healthcare plc
UDG Healthcare plc
UDG Healthcare plc specialises in supply chain, packaging, medical, regulatory, and sales and marketing services. They provide innovative, outsourced services that deliver outstanding results for healthcare companies and enable them to bring their products quickly to market.
year
2019
rev ($mm)
$1,298.52
EBITDA ($mm)
$178.30
EBIT ($mm)
$122.78
Net Income ($mm)
$57.45
Employees
7790
  • drill down
  • watch
Ticker: PDII
 
 
 
 
 
 
 
 
PDI, Inc.
PDI, Inc.
PDI is a leading healthcare commercialization company providing go-to-market strategy and execution to established and emerging pharmaceutical, biotechnology, diagnostics and healthcare companies in the United States.
year
2015
rev ($mm)
$140.12
EBITDA ($mm)
($14.89)
EBIT ($mm)
($19.53)
Net Income ($mm)
Employees
952
  • drill down
  • watch
Ticker: CNSX:TCAN
 
 
 
 
 
 
 
 
TransCanna
TransCanna
TransCanna specializes in assisting cannabis farmers and manufacturers get recognized by end consumers who in turn purchase their products. They offer our services throughout every aspect of the ecosystem; from branding and design, to transportation and distribution, to marketing and sales.
year
2017
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
($1.66)
Net Income ($mm)
Employees
0
  • drill down
  • watch
Ticker: TSE:6095
 
 
 
 
 
 
 
 
MedPeer,Inc.
MedPeer,Inc.
MedPeer provides appropriate services at every stage of the clinical process physicians are involved in day-to-day clinical operation. Drug Evaluation provides detailed peer reviews of prescription drugs, and Meet the Experts allows members to consult expert physicians in specific therapeutic areas.
year
2016
rev ($mm)
$9.13
EBITDA ($mm)
$0.94
EBIT ($mm)
$0.39
Net Income ($mm)
$0.20
Employees
44
  • drill down
  • watch
Ticker: TDOC
 
 
 
 
 
 
 
 
TelaDoc, Inc.
TelaDoc, Inc.
Teladoc is the nation’s first and largest telehealth provider with more than 6 million members nationwide. Teladoc enhances access to affordable, high-quality medical care for adults and children via videoconferencing or telephone consultations.
year
2020
rev ($mm)
$716.29
EBITDA ($mm)
($8.58)
EBIT ($mm)
($53.74)
Net Income ($mm)
Employees
2727
  • drill down
  • watch
Ticker: AIM:MED
 
 
 
 
 
 
 
 
MedaPhor
MedaPhor
MedaPhor is a global provider of advanced ultrasound training simulators for medical professionals. Founded in 2004, they have headquarters in Cardiff, UK and San Diego, USA, and our customers are some of the world's leading medical institutions.
year
2017
rev ($mm)
$5.48
EBITDA ($mm)
($2.09)
EBIT ($mm)
($2.82)
Net Income ($mm)
Employees
31
  • drill down
  • watch